DNASTAR

1:45 PM - 2:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104A
DNASTAR is a leader in developing innovative software for comprehensive sequence assembly and analysis, protein structure prediction, antibody modeling and design, and molecular docking.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
WI
Company HQ Country:
United States
Year Founded:
1984
Main Therapeutic Focus:
Tools/Drug Development Support Tech
Lead Product in Development:
In silico antibody design and development pipeline
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
Principal Scientist
DNASTAR, Inc.